Sunday, December 19, 2010 6:40:07 PM
-on july 27 MRES changed from a Mining Co to a MEDICAL company
http://finance.yahoo.com/news/NeuroBiote...
MRES has acquired a worldwide based biotechnological enterprise involved in the unique international niche of clinical neuroscience diagnostic testing. Neuro-Biotech's presently has the opportunity to market 12 clinical "Neuro Blood Tests" through partnerships.
http://neuro-biotechcorp.com/
http://finance.yahoo.com/news/NeuroBiote...
-New CEO Dr Claude Poulin Nominated as New CEO
he owns and operates a Lachute medical clinic where he continues to practice to this day
http://finance.yahoo.com/news/Mr-Claude-...
-new website is UP !!
http://neuro-biotechcorp.com/
important NOTE 1 :
One of the most noticeable differences between MRES and the other companies working in the field of Nanotechnology and Biotechnology is that we don't need to finance any further R&D (research and development), as this process has been completed during the past 30 years and our products have been tested according to standardized protocols in this domain. Therefore, R&D has been completed and the products are ready to be brought to the market. Some are already in the process of being ordered and negotiations are currently underway with several interested parties in various countries.
NOTE 2:MRES has first focused on SymPath(R) with
US patent (US 5879902) GRANTED IN 1999
article in Entrepreneur about patent :
Neuro-Biotech, Inc. (Sainte-Foy, Canada) has patented an in vitro diagnostic method for the determination of specific dopamine- beta -hydroxylase activity for the evaluation of the sympathetic nervous system function of a patient from a serum sample. (US 5879902)
http://savvy.entrepreneur.com/tradejourn...
about SymPath(R)
http://neuro-biotechcorp.com/en/site/dis...
the company was dormant and friday went into record volume
but on traders hands from Stockegg.com that profit taken Eod
more action is going to come with MRES
SEAB MM was buying crazy friday from traders
watch for action monday morning
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_N/threadview?m=tm&bn=78041&tid=29&mid=29&tof=1&frt=2
Recent MRES News
- M2Bio Sciences Appoints Adrian J. Maizey, Accomplished CEO and Financial Expert, to Advisory Board • InvestorsHub NewsWire • 07/19/2023 01:18:56 PM
- M2Bio Sciences Unveils an Exciting Line of Purple, White, and Green Teas from Kenya, Offering Extraordinary Health and Medicinal Benefits • InvestorsHub NewsWire • 07/14/2023 12:52:00 PM
- M2Bio Sciences Unveils Explainer Video Showcasing Groundbreaking NFTs and Altcoins for Drug Discovery, Revolutionizing Investment Access • InvestorsHub NewsWire • 07/06/2023 01:38:23 PM
- Institute of Biomedical Research Announces Application for Name Change and New Ticker Symbol in Anticipation of Future M&A Activities and Senior Listing • InvestorsHub NewsWire • 07/05/2023 02:04:17 PM
- M2Bio Sciences Enters into Letter of Intent to Acquire Crypto Exchange JDAX • InvestorsHub NewsWire • 06/26/2023 12:45:19 PM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM